How an Ayurvedic formulation is standardised

A conventional tablet contains a single active molecule at a stated dose, and two batches are interchangeable because chemistry says so. A classical Ayurvedic formulation is a different kind of object: it may contain a dozen plants, each contributing hundreds of compounds, grown in different soils, harvested in different seasons, and processed by a method described centuries before analytical chemistry existed. Standardisation is the discipline that makes such a product reproducible — so that the batch a patient takes this year behaves like the one studied last year.

The first question is whether it is the right plant

Every quality problem downstream begins with misidentification. The same vernacular name often covers several botanical species, adulteration with cheaper look-alikes is common, and substitution is sometimes traditional rather than fraudulent. Authentication therefore comes first, and it works at several levels:

• Macroscopic and organoleptic examination of the raw drug — form, colour, odour, taste, fracture.
• Microscopic study of characteristic cell structures, still one of the most reliable tools in pharmacognosy.
• DNA barcoding, increasingly used where morphology is destroyed, as in powdered material.

Only once the identity of every raw drug is fixed does the rest of standardisation mean anything.

Then the numbers that describe a batch

A raw drug and a finished formulation are each characterised by a set of agreed parameters. Pharmacognostic and physico-chemical values include moisture content, total ash and acid-insoluble ash (which reveal soil and sand contamination), extractive values in water and alcohol, pH, and particle size. These do not identify the active ingredients, but they detect adulteration, poor drying and careless handling quickly and cheaply.

Beyond them sit the chemical parameters, and here herbal medicine faces its structural difficulty: for most formulations no single compound is the active one. The field works around this in two complementary ways:

• Marker compounds — a characteristic constituent is chosen and quantified by HPLC or similar, not necessarily because it produces the therapeutic effect, but because it reliably indicates the plant and tracks its quality. Withanolides for ashwagandha and curcuminoids for turmeric are familiar examples.
• Chromatographic fingerprinting — HPTLC, HPLC or GC-MS produces a pattern of many peaks that represents the whole extract. The fingerprint of a new batch is compared against a reference pattern, so consistency is judged across the full chemical profile rather than one molecule.

A herbal medicine cannot be reduced to its loudest molecule. Standardising one is less like checking a lock's key than like recognising a face — the whole pattern has to match, not a single feature.

Safety limits and process control

Standardisation is also a safety exercise. Pharmacopoeial limits apply to heavy metals (lead, cadmium, mercury, arsenic), pesticide residues, aflatoxins and microbial load — contamination that plants readily pick up from soil, water and storage. Metal-containing bhasma preparations are a distinct case, judged by their own classical and analytical tests rather than by the limits applied to plant drugs.

Because a classical formulation is defined as much by its process as its ingredients, standard manufacturing procedures fix what the text describes qualitatively: the number of trituration cycles, decoction volume reduction, temperature, and duration. Stability studies then establish shelf life. In India, the Ayurvedic Pharmacopoeia of India lays down monographs for single drugs and formulations, and AYUSH-notified GMP rules govern manufacture.

Why it matters for students and researchers

Standardisation is what allows traditional medicine to be studied with modern methods at all — without batch consistency, a clinical trial cannot be interpreted or replicated. The research frontier includes metabolomic fingerprinting, network pharmacology for multi-component synergy, bioassay-guided rather than purely chemical standardisation, and better marker selection where classical actives are unknown. It draws on pharmacognosy, analytical chemistry, botany and regulatory science together. Following the peer-reviewed literature is how Ayurveda, pharmacy and life-science students and professionals keep pace with a field where India's traditional knowledge base and international quality expectations are actively being reconciled.

Frequently asked questions

What does standardisation of an Ayurvedic medicine mean?

It means establishing that every batch is the same in identity, composition, purity and strength, despite natural variation in plant material. This covers authentication of raw drugs, physico-chemical parameters, chemical marker or fingerprint profiles, contaminant limits and controlled manufacturing processes.

What are marker compounds in herbal standardisation?

Marker compounds are characteristic chemical constituents chosen to be measured in a plant or formulation. They may or may not be responsible for the therapeutic effect, but they can be quantified reliably and serve as an indicator of correct identity and consistent quality.

Why is fingerprinting used for herbal medicines?

Because a herbal product contains hundreds of compounds and rarely one clear active, a single-marker assay can miss variation elsewhere in the extract. Chromatographic fingerprinting captures the whole pattern of constituents, so a batch can be compared against a reference profile as a whole.

Which standards govern Ayurvedic medicines in India?

The Ayurvedic Pharmacopoeia of India provides official monographs specifying identity, purity and strength parameters for single drugs and classical formulations, alongside GMP requirements notified under the Drugs and Cosmetics Act and administered through the Ministry of AYUSH.